I owned this stinky pinky last year when they first jumped on the mmj band wagon and it did not work out for them and stock sank. The fact that they call themselves a pharma co screams legit but be careful. As it did the same last year, there will be a big lull in news, set-backs and investors will bail IMO. This is in addition near term (potential)manipulation IMO. I'd like to buy-in at .0018 after dump IMO. GLTA